Please use this identifier to cite or link to this item: https://doi.org/10.1155/2010/624040
Title: Peripheral T-cell lymphoma: Review and updates of current management strategies
Authors: Lim, S.T 
Tang, T 
Tay, K
Quek, R 
Tao, M 
Tan, S.Y 
Tan, L
Keywords: alemtuzumab
bleomycin
cyclophosphamide
cytarabine
denileukin diftitox
dexamethasone
doxorubicin
etoposide
fluorodeoxyglucose
gemcitabine
histone deacetylase inhibitor
methotrexate
pralatrexate
prednisolone
romidepsin
vincristine
vorinostat
add on therapy
allogeneic stem cell transplantation
apoptosis
autologous stem cell transplantation
B cell lymphoma
cancer combination chemotherapy
cancer incidence
cancer patient
cancer regression
cancer risk
cancer therapy
clinical assessment
clinical trial (topic)
computer assisted emission tomography
computer assisted tomography
cutaneous T cell lymphoma
cytomegalovirus infection
disease severity
drug dose increase
drug fatality
epidemiological data
event free survival
gene expression profiling
graft versus host reaction
histopathology
human
immunohistochemistry
immunophenotyping
infection
invasive aspergillosis
JC virus encephalopathy
laboratory test
multicenter study (topic)
multiple cycle treatment
neutropenia
NK T cell lymphoma
overall survival
peripheral T cell lymphoma
physical examination
Pneumocystis pneumonia
positron emission tomography
priority journal
prognosis
progression free survival
prospective study
review
risk factor
stem cell transplantation
T cell lymphoma
treatment response
tuberculosis
virus pneumonia
virus retinitis
Issue Date: 2010
Publisher: Hindawi
Citation: Lim, S.T, Tang, T, Tay, K, Quek, R, Tao, M, Tan, S.Y, Tan, L (2010). Peripheral T-cell lymphoma: Review and updates of current management strategies. Advances in Hematology 2010 : 624040. ScholarBank@NUS Repository. https://doi.org/10.1155/2010/624040
Rights: Attribution 4.0 International
Abstract: The classification of T-cell and natural-killer- (NK-) cell lymphomas has been updated in the 4th edition of the World Health Organization (WHO) classification of tumors of the haematopoietic and lymphoid tissue published in 2008. Based on recent epidemiological studies, NK-cell lymphomas occur almost exclusively in Asia and South America, although T-cell lymphomas appear to occur in the East as commonly as in the West. Due to the low prevalence of this disease, diagnosis and optimal treatment of patients have not been studied prospectively in large randomized trials. Nevertheless, there has been development in the understanding of T-cell lymphomas and how they should be managed; FDG-PET emerges as an increasingly important tool in diagnosis, gene-expression signatures may aid with prognostication in the future, and novel therapies are currently being studied to improve outcomes in T-cell lymphomas. More work, however, needs to be done, and international collaboration will be pertinent to deriving meaningful results from future clinical studies. © 2010 Tiffany Tang et al.
Source Title: Advances in Hematology
URI: https://scholarbank.nus.edu.sg/handle/10635/178192
ISSN: 1687-9104
DOI: 10.1155/2010/624040
Rights: Attribution 4.0 International
Appears in Collections:Staff Publications
Elements

Show full item record
Files in This Item:
File Description SizeFormatAccess SettingsVersion 
10_1155_2010_624040.pdf1.21 MBAdobe PDF

OPEN

NoneView/Download

SCOPUSTM   
Citations

8
checked on Nov 28, 2020

Page view(s)

6
checked on Nov 26, 2020

Google ScholarTM

Check

Altmetric


This item is licensed under a Creative Commons License Creative Commons